Menu
At Xsensio, we are pioneering a new era of patient monitoring with our Lab-on-Skin(c) sensing platform. Designed for real-time, continuous tracking of inflammation and other critical biomarkers, our technology enables earlier detection of clinical deterioration — from ICU settings to outpatient care and the home.
Our first product focuses on early detection of organ dysfunction, addressing high-impact challenges in critical care, oncology, and post-surgical recovery. Backed by strong IP and leading clinical collaborations, we are transforming how and when care decisions are made — empowering healthcare providers with actionable data when it matters most.
The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
info@xsensio.com
Sign up to get reports of our most recent activity.
